Compound ID | 913
Class: Glycopeptide, thiazolopeptide
| Spectrum of activity: | Gram-positive |
| Details of activity: | Lower MICs than vancomycin and teicoplanin against S. aureus, coagulase negative staphylococci amf glycopeptide susceptible and resistant enterococci |
| Description: | Berti M, Arain T, Goldstein BP, et al. Antimicrobial activity of MDL 63246, a new semi-synthetic glycopeptide antibiotic. 33rd-Intersci-Conf-Antimicrobial-Agents-Chemother 1993; 200. |
| Institute where first reported: | Biosearch Italia (Pfizer, USA) |
| Year first mentioned: | 1993 |
| Highest development stage: | Preclinical |
| Development status: | Inactive |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/17748716 |
| Citation: | http://aac.asm.org/content/39/7/1580.full.pdf |